L'Oréal Groupe: Cell BioPrint
The Future of Personalized Skin Care
At CES 2025 in Las Vegas, L'Oréal unveiled Cell BioPrint, a breakthrough skin analysis technology developed in partnership with Korean startup NanoEnTek.
This cutting-edge innovation provides a comprehensive and personalized skin diagnosis in just five minutes, ushering in a new era in cosmetic skin care.
A Breakthrough in Skin Diagnostics
Cell BioPrint provides a rapid and accurate analysis of the biological age of the skin. The technology examines proteins present in skin cells and their impact on aging. The diagnostic process is simple: an adhesive patch is applied to the cheek, then immersed in a special solution before being placed in the Cell BioPrint device for analysis.
During the analysis, a complementary tool, Skin Connect, captures multiple images of the face while a short questionnaire gathers insights into the user's skin care concerns. This combination of data provides an even more accurate assessment. The entire process, from sample collection to final results, takes just five minutes - a significant leap forward from traditional skin analysis, which can take days or even weeks. Cell BioPrint will be launched in Asia this year under a L'Oréal Groupe brand.
A technology that redefines skin care
Cell BioPrint revolutionizes skin care with three key scientific advancements in skin diagnostics. First, the device determines the skin's biological age – its "real" age – by analyzing its composition. This insight helps understand how skin ages and enables personalized skincare routines that effectively slow the signs of aging.
Second, the technology predicts how an individual's skin will respond to key ingredients, such as retinol. This breakthrough allows users to select the most appropriate skincare products for their specific skin needs.
Finally, Cell BioPrint shifts skin care from a reactive to a proactive approach. Instead of treating skin problems after they occur, the device anticipates them. For example, it can predict the likelihood of pigmentation spots forming before they become visible, enabling preventive interventions.
These three innovations respond to strong consumer demand for personalized skin care. According to a study conducted by OnePoll and Cerave, 80% of skin care users try multiple products before finding the right one. Cell BioPrint offers a scientific and personalized alternative to this trial-and-error approach.
The launch of Cell BioPrint marks a turning point for the cosmetics industry - personalized skincare is no longer a trend, but a scientific reality. More than just a technological innovation, it reflects L'Oréal's commitment to pushing the boundaries of science in the service of beauty. The future of skincare will be more personalized and precise, empowering individuals to achieve their best skin with data-driven recommendations.